- Home
- REGN vs AIG Comparison
REGN vs AIG Comparison
Compare REGN & AIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REGN
- AIG
- Stock Information
- Founded
- REGN 1988
- AIG 1919
- Country
- REGN United States
- AIG United States
- Employees
- REGN N/A
- AIG N/A
- Industry
- REGN Biotechnology: Pharmaceutical Preparations
- AIG Life Insurance
- Sector
- REGN Health Care
- AIG Finance
- Exchange
- REGN Nasdaq
- AIG Nasdaq
- Market Cap
- REGN 56.7B
- AIG 49.2B
- IPO Year
- REGN 1991
- AIG N/A
- Fundamental
- Price
- REGN $567.74
- AIG $81.83
- Analyst Decision
- REGN Buy
- AIG Buy
- Analyst Count
- REGN 22
- AIG 14
- Target Price
- REGN $840.95
- AIG $87.64
- AVG Volume (30 Days)
- REGN 987.0K
- AIG 4.3M
- Earning Date
- REGN 08-01-2025
- AIG 08-06-2025
- Dividend Yield
- REGN 0.62%
- AIG 2.20%
- EPS Growth
- REGN 16.49
- AIG N/A
- EPS
- REGN 39.43
- AIG N/A
- Revenue
- REGN $14,085,700,000.00
- AIG $26,858,000,000.00
- Revenue This Year
- REGN N/A
- AIG $3.37
- Revenue Next Year
- REGN $6.77
- AIG $3.55
- P/E Ratio
- REGN $14.40
- AIG N/A
- Revenue Growth
- REGN 7.52
- AIG N/A
- 52 Week Low
- REGN $476.49
- AIG $69.00
- 52 Week High
- REGN $1,211.20
- AIG $88.07
- Technical
- Relative Strength Index (RSI)
- REGN 63.13
- AIG 39.89
- Support Level
- REGN $532.60
- AIG $82.35
- Resistance Level
- REGN $559.46
- AIG $83.56
- Average True Range (ATR)
- REGN 14.29
- AIG 1.32
- MACD
- REGN 6.52
- AIG -0.37
- Stochastic Oscillator
- REGN 98.82
- AIG 1.44
About REGN Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
About AIG American International Group Inc. New
American International Group is one of the largest insurance and financial services firms in the world and has a global footprint. It operates through a wide range of subsidiaries that provide property, casualty, and life insurance. The company recently spun off its life insurance operations (Corebridge), but still retains a minority stake.